Verition Fund Management LLC Incyte Corp Transaction History

Verition Fund Management LLC

$13 Billion
Q1 2024

A detailed history of Verition Fund Management LLC transactions in Incyte Corp stock. As of the latest transaction made, Verition Fund Management LLC holds 28,482 shares of INCY stock, worth $1.73 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

28,482

Previous 10,119 181.47%

Holding current value

$1.73 Million

Previous $635,000 155.43%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$56.55 - $66.59 $1.04 Million - $1.22 Million	18,363 Added 181.47%	28,482 $1.62 Million
Q4 2023 Feb 14, 2024	SELL	$52.16 - $64.19 $771,133 - $948,984	-14,784 Reduced 59.37%	10,119 $635,000
Q3 2023 Nov 14, 2023	BUY	$57.77 - $65.93 $275,447 - $314,354	4,768 Added 23.68%	24,903 $1.44 Million
Q2 2023 Aug 14, 2023	BUY	$60.95 - $75.51 $1.23 Million - $1.52 Million	20,135 New	20,135 $1.25 Million
Q3 2022 Nov 14, 2022	SELL	$66.18 - $82.86 $142,419 - $178,314	-2,152 Reduced 33.49%	4,274 $285,000

Q2 2022 Aug 15, 2022	BUY	$66.18 - $83.18 $425,272 - $534,514	6,426 New	6,426 $488,000
Q1 2022 May 13, 2022	SELL	$66.02 - $79.71 $27.6 Million - $33.4 Million	-418,792 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $25.2 Million - $29.5 Million	397,860 Added 1900.73%	418,792 $30.7 Million
Q3 2021 Nov 15, 2021	BUY	$68.67 - $84.02 $1.24 Million - $1.51 Million	17,997 Added 613.19%	20,932 $1.44 Million
Q2 2021 Aug 16, 2021	SELL	$79.87 - $87.53 $190,410 - $208,671	-2,384 Reduced 44.82%	2,935 $247,000
Q1 2021 May 18, 2021	BUY	$76.02 - $100.5 $404,350 - $534,559	5,319 New	5,319 $0
Q4 2020 Feb 16, 2021	SELL	$80.74 - $97.7 $438,660 - $530,804	-5,433 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$85.07 - $109.69 $462,185 - $595,945	5,433 New	5,433 $488,000
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $1.36 Million - $1.85 Million	-21,463 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$73.04 - $95.72 $1.57 Million - $2.05 Million	21,463 New	21,463 $1.87 Million
Q3 2019 Nov 14, 2019	SELL	$72.82 - $86.52 $325,723 - $387,003	-4,473 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$73.52 - $88.7 $1.66 Million - $2.01 Million	-22,614 Reduced 83.49%	4,473 $380,000
Q1 2019 May 15, 2019	BUY	$63.56 - $88.17 $1.08 Million - $1.49 Million	16,949 Added 167.18%	27,087 $2.33 Million
Q4 2018 Feb 14, 2019	SELL	$58.5 - $69.94 $534,631 - $639,181	-9,139 Reduced 47.41%	10,138 $645,000
Q3 2018 Nov 15, 2018	SELL	$61.75 - $74.23 $67,925 - $81,653	-1,100 Reduced 5.4%	19,277 $1.33 Million
Q2 2018 Aug 15, 2018	BUY	$60.85 - $83.98 $882,994 - $1.22 Million	14,511 Added 247.37%	20,377 $1.37 Million
Q1 2018 May 16, 2018	SELL	$83.06 - $100.98 $184,144 - $223,872	-2,217 Reduced 27.43%	5,866 $489,000
Q4 2017 Feb 15, 2018	BUY	$93.56 - $116.6 $756,245 - $942,477	8,083	8,083 $766,000

Others Institutions Holding INCY

# of Institutions

617

Shares Held

215M

Call Options Held

366K

Put Options Held

445K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $13.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Account

Verition Fund Management LLC Incyte Corp Transaction History